⛑️ Life Sciences AI Startups had a field day

DM on Twitter for Sponsorships

Top picks

A quick highlight

Iambic Therapeutics

Amount: $100M 🎉

Round: Series B

Lead Investors: Abingworth, Ascenta Capital

Iambic Therapeutics aims to revolutionize drug discovery and speed up the market with highly selective drugs. They are focused on delivering best-in-class and first-in-class development candidates to the clinic.

They are developing novel therapeutics from its unique generative AI discovery platform. They have identified potential first-in-class and best-in-class development candidates years faster than industry norms.

Unitary

Amount: $15M 🎉

Round: Series A

Lead Investor: Creandum

Unitary AI aims to tackle the challenge of content moderation by using a “multimodal” approach to help parse content in videos.

Unitary AI uses AI to assess the level of risk and harm in user-generated content uploaded to social media. They are currently classifying 6 million videos per day.

AI Clearing

Amount: $14M 🎉

Round: Series A

Lead Investor: Prudence

AI Clearing aims to transform the construction industry through artificial intelligence solutions designed to enhance construction project efficiency and outcomes.

The end users are contractors, owners, and lenders involved in large infrastructure projects such as utility-scale solar, railways, roads, pipelines, airports, industrial, and power transmission lines. These projects typically have budgets in the hundreds of millions of dollars, with millions of items to be constructed or installed on-site.

Before AI Clearing, these large sites were tracked manually, with 5-10% sample area covered monthly. This was insufficient for accurate project control and often resulted in substantial budget overruns, delays, and disputes between the involved parties. AI Clearing’s technology is fully automated and compares the on-site progress to the design, budget, and schedule.

Lokavant

Amount: $8M 🎉

Round: Series A

Lead Investors: Mitsui & Co

Lokavant aims to address the significant issues present in planning and conducting complex global clinical trials.

Their Clinical Trial Intelligence Platform provides sponsors and CROs with real-time, predictive analytics in a continuous feedback loop, resulting in a 70x improvement in enrollment forecast accuracy, over $1 million in cost savings from patient retention, and six months’ time savings from detecting site noncompliance issues.

Humata

Amount: $3.5M 🎉

Round: Seed

Lead Investor: Gradient Ventures

Humata AI’s mission is to empower people and organizations to make smarter and faster decisions by being able to ask questions across all their files.

They have developed an AI platform that simplifies complex research publications and helps accelerate scientific discovery. Users can ask AI-powered queries about their data and files and get instant answers. This feature makes it easy to discover new insights and save time by learning faster and working smarter.

Careers 📢

Believe in Iambic Therapeutics’ mission? Join them 👇

Believe in AI Clearing’s mission? Join them 👇

Chief AI Tool of the Day 📢

Chat your way through long documents. Command our AI to summarize for you. Check it out 👇

Bonus 🔥

For the most curious minds!